Did you know that every major advance in the fight against breast cancer has been touched by Susan G. Komen ®? That we’ve provided more money for breast cancer research and community health programs than any entity besides the U.S. government? Komen’s goal is to “energize science to find the cures.”
Komen’s commitment to supporting life-saving research has never been stronger. Building on 27 years of funding research to find the causes and cures of breast cancer, Komen continues its important new focus on research that will speed the translation of discoveries into reductions in breast cancer mortality and/or incidence within the next decade and on addressing disparities in breast cancer across populations.
A minimum of 25 percent of the net income from each Affiliate supports the Komen Research, Evaluation and Scientific Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.
Information about National Research Programs
We have made a promise to end breast cancer forever – energizing science to find the cures is a critical part of this promise. Click here to read more about some that are fulfilling this promise.
Susan G. Komen® is the largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since 1982, Komen has contributed to many of the advances made in the fight against breast cancer, transforming how the world treats and talks about this disease and helping many more people become breast cancer survivors. For more information about breast cancer research click here.
Komen’s Mission Advisors are rock stars—the best and brightest breast cancer researchers, clinicians, advocates and other experts who help guide and implement our mission programs. Thanks to their efforts, we’re driving discovery, affecting change and accelerating progress in the fight against breast cancer. For more information about Komen’s Mission Advisors click here.